Health X Platform credit ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
22.122.10.00.00.0
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−8.1−8.1−12.4−49.0−195
0.03×0.03×0.00×0.00×0.00×
−0.01×−0.01×−0.01×−0.05×−0.20×
−0.42×−0.42×0.00×0.00×0.00×
0.12×0.16×0.22×−9.04×4.44×
−75.12×−75.12×−284.78×−3.69×−60.12×
2.8%2.8%0.0%0.0%0.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HEALTHX₹279.20

Health X Platform Limited

· Pharma & Health
₹ CrorePeersSURAKSHAKRSNAANEPHROPLUS3BBLACKBIOMcap ₹888 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt0.00.00.022.122.1
Net Debt-195.2-49.0-12.4-8.1-8.1
Total Debt/Equity0.000.000.000.030.03
Net Debt/Equity-0.20-0.05-0.01-0.01-0.01
Total Debt/EBITDA0.000.000.00-0.42-0.42
Net Debt/EBITDA4.44-9.040.220.160.12
Interest Coverage (EBIT/Interest)-60.12-3.69-284.78-75.12-75.12
Total Debt/Total Capital %0.000.000.002.812.81
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.